| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 164.34 | 81 |
| GSM780708 | Untreated after 4 days (C2_1) | 126.915 | 78 |
| GSM780709 | Untreated after 4 days (C3_1) | 107.285 | 76 |
| GSM780719 | Untreated after 4 days (C1_2) | 181.994 | 83 |
| GSM780720 | Untreated after 4 days (C2_2) | 144.313 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 121.175 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 332.391 | 88 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 270.712 | 86 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 397.726 | 90 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 307.453 | 88 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 292.838 | 87 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 440.631 | 91 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 283.386 | 87 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 202.506 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 333.245 | 88 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 293.96 | 87 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 210.326 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 332.391 | 88 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 174.458 | 82 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 276.761 | 87 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 247.394 | 86 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 165.545 | 82 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 214.156 | 84 |